Literature DB >> 34112824

Serum free culture for the expansion and study of type 2 innate lymphoid cells.

Pablo de Lucía Finkel1,2,3,4,5, Christopher Sherwood1, Iryna Saranchova1,2,3,4,5,6,7,8, Wenjing Xia1,2,3,4,5, Lonna Munro1,2,3,4,5,6,7,8, Cheryl G Pfeifer1,2,3,4,5,6,7,8, James M Piret1,9,10, Wilfred A Jefferies11,12,13,14,15,16,17,18.   

Abstract

Type 2 innate lymphoid cells (ILC2s) were discovered approximately ten years ago and their clinical relevance is gaining greater importance. However, their successful isolation from mammalian tissues and in vitro culture and expansion continues to pose challenges. This is partly due to their scarcity compared to other leukocyte populations, but also because our current knowledge of ILC2 biology is incomplete. This study is focused on ST2+ IL-25Rlo lung resident ILC2s and demonstrate for the first time a methodology allowing mouse type 2 innate lymphoid cells to be cultured, and their numbers expanded in serum-free medium supplemented with Interleukins IL-33, IL-2, IL-7 and TSLP. The procedures described methods to isolate ILC2s and support their growth for up to a week while maintaining their phenotype. During this time, they significantly expand from low to high cell concentrations. Furthermore, for the first time, sub-cultures of primary ILC2 purifications in larger 24- and 6-well plates were undertaken in order to compare their growth in other media. In culture, ILC2s had doubling times of 21 h, a growth rate of 0.032 h-1 and could be sub-cultured in early or late phases of exponential growth. These studies form the basis for expanding ILC2 populations that will facilitate the study and potential applications of these rare cells under defined, serum-free conditions.

Entities:  

Year:  2021        PMID: 34112824     DOI: 10.1038/s41598-021-91500-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  52 in total

Review 1.  Lung ILC2s link innate and adaptive responses in allergic inflammation.

Authors:  Itziar Martinez-Gonzalez; Catherine A Steer; Fumio Takei
Journal:  Trends Immunol       Date:  2015-02-19       Impact factor: 16.687

Review 2.  Innate Lymphoid Cells: 10 Years On.

Authors:  Eric Vivier; David Artis; Marco Colonna; Andreas Diefenbach; James P Di Santo; Gérard Eberl; Shigeo Koyasu; Richard M Locksley; Andrew N J McKenzie; Reina E Mebius; Fiona Powrie; Hergen Spits
Journal:  Cell       Date:  2018-08-23       Impact factor: 41.582

3.  Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells.

Authors:  Kazuyo Moro; Taketo Yamada; Masanobu Tanabe; Tsutomu Takeuchi; Tomokatsu Ikawa; Hiroshi Kawamoto; Jun-Ichi Furusawa; Masashi Ohtani; Hideki Fujii; Shigeo Koyasu
Journal:  Nature       Date:  2009-12-20       Impact factor: 49.962

4.  IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.

Authors:  Virginie Carriere; Lucie Roussel; Nathalie Ortega; Delphine-Armelle Lacorre; Laure Americh; Luc Aguilar; Gérard Bouche; Jean-Philippe Girard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 11.205

Review 5.  The role of ILC2 in pathology of type 2 inflammatory diseases.

Authors:  Jochem H Bernink; Kristine Germar; Hergen Spits
Journal:  Curr Opin Immunol       Date:  2014-10-30       Impact factor: 7.486

Review 6.  Interactions between innate and adaptive lymphocytes.

Authors:  Georg Gasteiger; Alexander Y Rudensky
Journal:  Nat Rev Immunol       Date:  2014-08-18       Impact factor: 53.106

7.  Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity.

Authors:  Masashi Ikutani; Tsutomu Yanagibashi; Masaru Ogasawara; Koichi Tsuneyama; Seiji Yamamoto; Yuichi Hattori; Taku Kouro; Atsuko Itakura; Yoshinori Nagai; Satoshi Takaki; Kiyoshi Takatsu
Journal:  J Immunol       Date:  2011-12-14       Impact factor: 5.422

8.  Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells.

Authors:  Ben Roediger; Ryan Kyle; Kwok Ho Yip; Nital Sumaria; Thomas V Guy; Brian S Kim; Andrew J Mitchell; Szun S Tay; Rohit Jain; Elizabeth Forbes-Blom; Xi Chen; Philip L Tong; Holly A Bolton; David Artis; William E Paul; Barbara Fazekas de St Groth; Michele A Grimbaldeston; Graham Le Gros; Wolfgang Weninger
Journal:  Nat Immunol       Date:  2013-04-21       Impact factor: 25.606

9.  Type 2 innate lymphoid cells drive CD4+ Th2 cell responses.

Authors:  Ananda S Mirchandani; Anne-Gaelle Besnard; Edwin Yip; Charlotte Scott; Calum C Bain; Vuk Cerovic; Robert J Salmond; Foo Y Liew
Journal:  J Immunol       Date:  2014-01-27       Impact factor: 5.422

10.  Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation.

Authors:  Timotheus Y F Halim; Catherine A Steer; Laura Mathä; Matthew J Gold; Itziar Martinez-Gonzalez; Kelly M McNagny; Andrew N J McKenzie; Fumio Takei
Journal:  Immunity       Date:  2014-03-06       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.